Recent News

Proteostasis Therapeutics Exclusively Licenses Discoveries Related to Unfolded Protein Response from Ron Laboratory at New York University

Proteostasis Scientific Founders Publish Paper in Cell Establishing Role of the Proteostasis Network in Alzheimer's Disease

Proteostasis Therapeutics is discovering and developing novel small molecule therapeutics designed to control the body’s protein homeostasis, or Proteostasis Network.  The Proteostasis Network maintains the body’s natural balance of proteins to protect us from numerous diseases.  These novel therapies, or Proteostasis Regulators, are designed to treat multiple genetic and degenerative disorders associated with deficiencies of the Proteostasis Network, such as Alzheimer’s disease, emphysema, Huntington’s disease, and type II diabetes.